Where Does Wall Street Think Odonate Therapeutics Inc (ODT) Stock Will Go?

Friday, January 07, 2022 01:52 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Odonate Therapeutics Inc (ODT) Stock Will Go?

Wall Street is neutral on Odonate Therapeutics Inc (ODT). On average, analysts give ODT a Hold rating. The average price target is $4, which means analysts expect the stock to climb by 260.36% over the next twelve months. That average ranking earns ODT an Analyst Rating of 4, which is better than 4% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating ODT a Hold today. Find out what this means to you and get the rest of the rankings on ODT!

See Full ODT Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Odonate Therapeutics Inc Stock Today?

Odonate Therapeutics Inc (ODT) stock is trading at $1.11 as of 1:51 PM on Friday, Jan 7, a decline of -$0.20, or -15.27% from the previous closing price of $1.31. The stock has traded between $0.85 and $1.18 so far today. Volume today is above average. So far 5,999,035 shares have traded compared to average volume of 596,639 shares. Click Here to get the full Stock Report for Odonate Therapeutics Inc stock.